The pivotal role of nitric oxide: Effects on the nervous and immune systems

Current Pharmaceutical Design

Volumn 20, Issue 29, 2014, Pages 4679-4689

  Bañuls, Celia ^a   Rocha, Milagros ^a,b   Rovira Llopis, Susana ^a,b   Falcon, Rosa ^a,b   Castello, Raquel ^a,b   Herance, Jose R ^a   Polo, Miriam ^a,c   Blas Garcia, Ana ^a,c   Hernandez Mijares, Antonio ^a,b,c   Victor, Victor M ^a,b,c  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b Instituto Universitario IVI INCLIVA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Immune system; Leukocyte; Mitochondria; Nervous system; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; REACTIVE NITROGEN SPECIES;

ARTICLE; HUMAN; IMMUNE SYSTEM; INFECTION; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MOLECULAR BIOLOGY; NERVOUS SYSTEM; NITROSATIVE STRESS; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THYMUS; TRANSPLANTATION; HOMEOSTASIS; NERVOUS SYSTEM FUNCTION; PHYSIOLOGY;

HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; NITRIC OXIDE;

EID: 84906238878     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140130213510     Document Type: Article

References (177)

1. Bruckdorfer R. The basics about nitric oxide. Mol Asp Med 2005; 26: 3-31.
2. Kiechle FL, Malinski T. Nitric oxide. Biochemistry, pathophysiology, and detection. Am J Clin Pathol 1993; 100: 567-575.
3. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
4. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesión to vascular endothelium. Lancet 1987; 2: 1057-1058.
5. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655.
6. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
7. Carnovale CE, Ronco MT. Role of nitric oxide in liver regeneration. Ann Hepatol 2012; 11: 636-647.
8. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
9. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition: Biochem J 2001; 357: 593-615.
10. Schild L, Reinheckel T, Reiser M, Horn TF, Wolf G, Augustin W. Nitric oxide produced in rat liver mitochondria causes oxidative stress and impairment of respiration after transient hypoxia. FASEB J 2002; 17: 2194-2201.
11. Carreras MC, Poderoso JJ. Mitochondrial nitric oxide in the signaling of cell integrated responses. Am J Cell Physiol 2007; 292: C1569-C1580.
12. Forstermann U, Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch Pharmacol 1995; 352: 351-364.
13. Gobeil F, Jr., Zhu T, Brault S, et al. Nitric oxide signaling via nuclearized endothelial-nitric oxide synthase modulates expression of the immediate genes iNOS and mPGES-1. J Biol Chem 2006; 281: 16058-16067.
14. Steel JH, Terenghi G, Chung JM, Na HS, Carlton SM, Polak JM. Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model. Neurosc Lett 1994; 169: 81-84.
15. Calatayud S, Barrachina MD, Esplugues JV. Nitric oxide: relation to integrity, injury, and healing of the gastric mucosa. Microsc Res Tech 2001; 53: 325-335.
16. Finocchietto PV, Franco MC, Holod S, et al. Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death. Exp Biol Med 2009; 234: 1020-1028.
17. Lisdero CL, Carreras MC, Meulemans A, et al. The mitocondrial interplay of ubiquinol and nitric oxide in endotoxemia. Methods Enzymol 2004; 382: 67-81.
18. López LC, Escames G, Tapias V, Utrilla P, León J, Acuña-Castroviejo D. Identification of an inducible nitric oxide synthase in diaphgram mitochondria from septic mice: its relation with mitochondrial dysfunction and prevention by melatonin. Int J Biochem Cell Biol 2006; 38: 267-278.
19. Taylor CT, Moncada S. Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol 2010; 30: 643-647.
20. Hobbs AJ, Higgs A, Moncada S. Inhibition of nitric oxide synthase as a potential therapeutical target. Annu Rev Pharmacol Toxicol 1999; 39: 191-220.
21. Kiechle FL, Malinski T. Nitric oxide. Biochemistry, pathophysiology, and detection. Am J Clin Pathol 1993; 100: 567-575.
22. Hantraye P, Brouillet E, Ferrante R, et al. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 1996; 2: 1017-1021.
23. Bae BI, Hara MR, Cascio MB, et al. Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH. Proc Natl Acad Sci USA 2006; 103: 3405-3409.
24. Sultana R, Poon HF, Cai J, et al. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 2006; 22: 76-87.
25. Wang Y, Golledge J. Neuronal nitric oxide synthase and sympathetic nerve activity in neurovascular and metabolic systems. Curr Neurovasc Res 2013; 10: 81-89.
26. Ridnour LA, Dhanapal S, Hoos M, et al. Nitric oxide-mediated regulation of P-amyloid clearance via alterations of MMP-9/TIMP-1. J Neurochem 2012; 123: 736-749.
27. Lipton SA, Choi YB, Pan ZH, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626-632.
28. Victor VM, Rocha M, Solá E, Bañuls C, Garcia-Malpartida K, Hernández-Mijares A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 2009; 15: 2988-3002.
29. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-258.
30. Nelson EJ, Connolly J, McArthur P. Nitric oxide and S-nitrosylation: excitotoxic and cell signaling mechanism. Biol Cell 2003; 95: 3-8.
31. Moncada S, Bolanos JP. Nitric oxide, cell bioenergetics and neu-rodegeneration. J Neurochem 2006; 97: 1676-1689.
32. Lee HK, Choi SS, Han EJ, Han KJ, Suh HW. Role of glutamate receptors and an on-going protein synthesis in the regulation of phosphorylation of Ca2_/calmodulin-dependent protein kinase II in the CA3 hippocampal region in mice administered with kainic acid intracerebroventricularly. Neurosci Lett 2003; 348: 93-96.
33. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 2005; 25: 9275-9284.
34. Hall ED, Wang JA, Miller DM. Relationship of nitric oxide syn-thase induction to peroxynitrite-mediated oxidative damage during the first week after experimental traumatic brain injury. Exp Neurol 2012; 238: 176-182.
35. Crane BR, Arvai AS, Ghosh DK, et al. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 1998; 279: 2121-2126.
36. Marletta MA. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 1994; 78: 927-930.
37. Michel T, Li GK, Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1993; 90: 6252-6256.
38. Mineo C, Shaul PW. Regulation of eNOS in caveolae. Adv Exp Med Biol 2012; 729: 51-62.
39. Ghafourifar P, Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 2005; 26: 190-195.
40. Ghafourifar P, Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett 1997; 418: 291-296.
41. Zaobornyj T, Ghafourifar P. Strategic localization of heart mito-chondrial NOS: a review of the evidence. Am J Physiol Heart Circ Physiol 2012; 303: H1283-H1293.
42. Dedkova EN, Ji X, Lipsius SL, Blatter LA. Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells. Am J Physiol Cell Physiol 2004; 286: C406-C415.
43. Kanai AJ, Pearce LL, Clemens PR, et al. Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci USA 2001; 98: 14126-14131.
44. Zenebe WJ, Nazarewicz RR, Parihar MS, Ghafourifar P. Hypoxia/reoxygenation of isolated rat heart mitochondria causes cytochrome c release and oxidative stress; evidence for involvement of mitochondrial nitric oxide synthase. J Mol Cell Cardiol 2007; 43: 411-419.
45. Mannick JB, Schonhoff C, Papeta N, et al. S-Nitrosylation of mito-chondrial caspases. J. Cell Biol 2001; 154: 1111-1116.
46. Ghafourifar P, Colton CA. Compartmentalized nitrosation and nitration in mitochondria. Antioxid. Redox Signal 2003; 5: 349-354.
47. A. Nedospasov, Rafikov R, Beda N, Nudler E. An autocatalytic mechanism of protein nitrosylation Proc Natl Acad Sci USA 2000; 97: 13543-13548.
48. E. Clementi, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 95 1998; pp: 7631-7636.
49. Dawson VL, Dawson TM. Nitric oxide in neurodegeneration. Prog Brain Res 1998; 118: 215-229.
50. Poderoso JJ, Lisdero C, Schopfer F, et al. The regulation of mito-chondrial oxygen uptake by redox reactions involving nitric oxide and ubiquinol. J Biol Chem 1999; 274: 37709-37716.
51. Cadenas E, Poderoso JJ, Antunes F, and Boveris A. Analysis of the pathways of nitric oxide utilization in mitochondria. Free Radic Res 2000; 33: 747-756.
52. Poderoso JJ. The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide. Arch Biochem Biophys 2009; 484: 214-220.
53. Stamler JS, Toone EJ, Lipton SA, Sucher NJ. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 1997; 18: 691-696.
54. Stamler JS, Lamas S, Fang FC. Nitrosylation. the prototypic redox-based signaling mechanism. Cell 2001; 106: 675-683.
55. Chung KK. Say NO to neurodegeneration: role of S-nitrosylation in neurodegenerative disorders. Neurosignals 2006; 15: 307-313.
56. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992; 298: 431-437.
57. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxynitrite. Nature 1993; 364: 584.
58. Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 1999; 31: 577-596.
59. Yuan C, Yi L, Yang Z, et al. Amyloid beta-heme peroxidase promoted protein nitrotyrosination: relevance to widespread protein nitration in Alzheimer's disease. J Biol Inorg Chem 2012; 17: 197-207.
60. Gaston B, Stamler JS. Biochemistry of nitric oxide. In: Fang FC, Ed. Nitric oxide and infection. New York: Kluwer Academic/Plenum Publishers 1999; pp: 37-55
61. Henson SE, Nichols TC, Holers VM, Karp DR. The ectoenzyme y-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes. J Immunol 1999; 163: 1845-1852.
62. Hernansanz-Agustín P, Izquierdo-Álvarez A, García-Ortiz A, Ibiza S, Serrador JM, Martínez-Ruiz A. Nitrosothiols in the immune system: signaling and protection. Antioxid Redox Signal 2013; 18: 288-308.
63. Renodon A, Boucher JL, Wu C, et al. Formation of nitric oxide synthase-iron(II) nitrosoalkane complexes: severe restriction of access to the iron(II) site in the presence of tetrahydrobiopterin. Biochemistry 1998; 37: 6367-6374.
64. Eiserich JP, Hristova M, Cross CE. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391: 393-397.
65. Marshall HE, Merchant K, Stamler JS. Nitrosation and oxidation in the regulation of gene expression. FASEB J 2000; 14: 1889-1900.
66. Bogdan C. Nitric oxide and the regulation of gene expression. Trends Cell Biol 2001; 11: 66-75.
67. Bogdan C. The function of nitric oxide in the immune system. In: Mayer B, Ed. Handbook of Experimental Pharmacology. Volume: Nitric Oxide. Heidelberg: Springer 2000; pp: 443-492.
68. Bauer H, Jung T, Tsikas D, Stichtenoth DO, Frölich JC, Neumann C. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology 1997; 90: 205-211.
69. Jimenez JL, Gonzalez-Nicolas J, Alvarez S, Fresno M, Munoz-Fernandez MA. Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide. J Virol 2001; 75: 4655-4663.
70. Reiling N, Kröncke R, Ulmer AJ, Gerdes J, Flad HD, Hauschildt S. Nitric oxide synthase: expression of the endothelial, Ca2+/calmodulin-dependent isoform in human B and T lymphocytes. Eur J Immunol 1996; 26: 511-516.
71. Ibiza S, Víctor VM, Boscá I, et al. Endothelial nitric oxide synthase regulates T cell receptor signaling at the immunological synapse. Immunity 2006; 24: 753-765.
72. Ibiza S, Pérez-Rodríguez A, Ortega A, et al. Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells. Proc Natl Acad Sci USA 2008; 105(30): 10507-10512.
73. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Ann Rev Immunol 1997; 15: 323-350.
74. Carpenter L, Cordery D, Biden TJ. Protein kinase Cd activation by interleukin-1p stabilizes inducible nitric oxide synthase mRNA in pancreatic (3-cells. J Biol Chem 2001; 276: 5368-5374.
75. Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 2005; 11(24): 3141-3158.
76. Stuehr D. Mammalian nitric oxide synthases. Biochim Biophys Acta 1999; 1411: 217-230.
77. Huang Z, Hoffmann FW, Fay JD, et al. Stimulation of unprimed macrophages with immune complexes triggers a low output of nitric oxide by calcium-dependent neuronal nitric-oxide synthase. J Biol Chem 2012; 287: 4492-4502.
78. Kania G, Siegert S, Behnke S, et al. Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis. Circulation 2013; 127: 2285-2294.
79. Pellacani A, Wiesel P, Razavi S, et al. Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric oxide synthase 2 by transforming growth factor-p1. J Biol Chem 2001; 276: 1653-1659.
80. Ganster RW, Taylor BS, Shao L, Geller DA. Complex regulation of human iNOS gene transcription by Stat1 and NF-kB. Proc Natl Acad Sci USA 2001; 98: 8638-8643.
81. Karaghiosoff M, Neubauer H, Lassnig C, et al. Partial impairment of cytokine responses in tyk2-deficient mice. Immunity 2000; 13: 549-560.
82. Chakravortty D, Kato Y, Sugiyama T, et al. The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophage cells: a role of Raf-1 in lipopolysaccharide signaling. J Immunol2001; 166: 2011-2017.
83. Poloso NJ, Urquhart P, Nicolaou A, Wang J, Woodward DF. PGE(2) differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP(2)/EP(4)). Mol Immunol 2013; 54: 284-295.
84. Connelly L, Palacios-Callender M, Ameixa C, Moncada S, Hobbs AJ. Biphasic regulation of NF-kB activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol 2001; 166: 3873-3881.
85. Förstermann U, Boissel JP, Kleinert H. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOSI and NOSIII). FASEB J 1998; 12: 773-790.
86. Musial A, Eissa NT. Inducible nitric oxide synthase is regulated by the proteasome degradation pathway. J Biol Chem 2001; 276: 24268-24273.
87. Hoang HH, Padgham SV, Meininger CJ. Larginine, tetrahydrobiopterin, nitric oxide and diabetes. Curr Opin Clin Nutr Metab Care 2013; 16: 76-82.
88. Ratovitski EA, Bao C, Quick RA, McMillan A, Kozlovsky C, Lowenstein CJ. An inducible nitric oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity. J Biol Chem 1999; 274: 30250-30257.
89. Lee KS, Lee DK, Jeoung D, et al. Differential effects of substrate-analogue inhibitors on nitric oxide synthase dimerization. Biochem Biophys Res Commun 2012; 418: 49-55.
90. Bucci M, Gratton JP, Rudic RD, et al. In vivo delivery of the cave-olin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nature Med 2000; 6: 1362-1367.
91. Pritchard KA Jr, Ackerman AW, Gross ER, et al. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric oxide synthase. J Biol Chem 2001; 276: 17621-17624.
92. Mineo C, Shaul PW. Regulation of eNOS in caveolae. Adv Exp Med Biol 2012; 729: 51-62.
93. Yue L, Bian JT, Grizelj I, et al. Apolipoprotein E enhances endo-thelial-NO production by modulating caveolin 1 interaction with endothelial NO synthase. Hypertension 2012; 60(4): 1040-1046.
94. Nuszkowski A, Gräbner R, Marsche G, Unbehaun A, Malle E, Heller R. Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislo-calization of endothelial nitric oxide synthase. J Biol Chem 2001; 276: 14212-14221.
95. Victor VM, Nuñez C, D'Ocón P, Taylor CT, Esplugues JV, Moncada S. Regulation of oxygen distribution in tissues by endothelial nitric oxide. Circ Res 2009; 104: 1178-1183.
96. Victor VM, Apostolova N, Herance R, Hernandez-Mijares A, Rocha M. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. Curr Med Chem 2009; 16: 4654-4667.
97. Turgeon J, Dussault S, Maingrette F, et al. Fish oil-enriched diet protects against ischemia by improving angiogenesis, endothelial progenitor cell function and postnatal neovascularization. Atherosclerosis 2013; 229: 295-303.
98. Coburn LA, Gong X, Singh K, et al. L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS One 2012; 7: e33546.
99. Bonhomme S, Belabed L, Blanc MC, Neveux N, Cynober L, Darquy S. Arginine-supplemented enteral nutrition in critically ill diabetic and obese rats: A dose-ranging study evaluating nutritional status and macrophage function. Nutrition 2013; 29: 305-312.
100. Munder M, Eichmann K, Morán JM, Centeno F, Soler G, Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 1999; 163: 3771-3777.
101. Gotoh T, Mori M. Arginase II downregulates nitric oxide (NO) production and prevents NO mediated apoptosis in murine macro-phage-derived RAW264.7 cells. J Cell Biol 1999; 144: 427-434.
102. Rutschman R, Lang R, Hesse M, Ihle JN, Wynn TA, Murray PJ. Stat6-dependent substrate depletion regulates nitric oxide production. J Immunol 2001; 166: 2173-2177.
103. Abu-Amara M, Yang SY, Seifalian A, Davidson B, Fuller B. The nitric oxide pathway-evidence and mechanisms for protection against liver ischaemia reperfusion injury. Liver Int 2012; 32: 531-543.
104. Nagasaki A, Gotoh T, Takeya M, et al. Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rats. J Biol Chem 1996; 271: 2658-2662.
105. Nielsen SS, Grøfte T, Tygstrup N, Vilstrup H. Cirrhosis and endotoxin decrease urea synthesis in rats. Hepatol Res 2007; 37: 540-547.
106. Flam BR, Hartmann PJ, Harrell-Booth M, Solomonson LP, Eichler DC. Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase and lyase, with endothelial nitric oxide synthase. Nitric Oxide 2001; 5: 187-197.
107. Werner-Felmayer G, Golderer G, Werner E. R. Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects. Curr Drug Metab 2002; 3: 159-173.
108. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 1997; 100: 2146-2152.
109. Morales-Ruiz M, Lee MJ, Zöllner S, et al. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem 2001; 276: 19672-19677.
110. Streit U, Reuter H, Bloch W, Wahlers T, Schwinger RH, Brixius K. Phosphorylation of myocardial eNOS is altered in patients suffering from type 2 diabetes. J Appl Physiol 2013; 114: 1366-742012.
111. Tyryshkin A, Gorgun FM, Abdel Fattah E, et al. Src kinase-mediated phosphorylation stabilizes inducible nitric-oxide synthase in normal cells and cancer cells. J Biol Chem 2010; 285: 784-792.
112. Fritzsche G, Larcher C, Schennach H, Weiss G. Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection. J Infect Dis 2001; 183: 1388-1394.
113. Robinson MA, Baumgardner JE, Otto CM. Oxygen-dependent regulation of nitric oxide production by inducible nitric oxide synthase. Free Radic Biol Med 2011; 51: 1952-1965.
114. Frucht DM, Fukao T, Bogdan C, Schindler H, O'Shea JJ, Koyasu S. Interferon-y production by antigen presenting cells: mechanisms emerge. Trends Immunol 2001; 22: 556-560.
115. Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 2001; 291: 1544-1547.
116. Freire-de-Lima CG, Nascimento DO, Soares MB, et al. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 2000; 403: 199-203.
117. Pfeilschifter J, Eberhardt W, Beck KF. Regulation of gene expression by nitric oxide. Pflugers Arch 2001; 442: 479-486.
118. Wink DA, Hines HB, Cheng RY, et al. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol 2011; 89: 873-891.
119. Zamora R, Vodovotz Y, Aulak KS, et al. A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-1 expression in ischemia/reperfusion. Nitric Oxide 2002; 7: 165-186.
120. Ehrt S, Schnappinger D, Bekiranov S, et al. Reprogramming of the macrophage transcriptome in response to interferon-y and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 2001; 194: 1123-1140.
121. Razny U, Kiec-Wilk B, Polus A, et al. The adipose tissue gene expression in mice with different nitric oxide availability. J Physiol Pharmacol 2010; 61: 607-618.
122. Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Rad Biol Med 1998; 25: 404-433.
123. Li J, Wu F, Zhang H, et al. Insulin inhibits leukocyte-endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol 2009; 47: 512-519.
124. Lefer DJ, Jones SP, Girod WG, et al. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol 1999; 276: H1943-H1950.
125. Victor VM, Rocha M, Bañuls C, et al. Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab 2011; 96: 3115-3122.
126. Hernandez-Mijares A, Rocha M, Rovira-Llopis S, et al. Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia. Diabetes Care 2013; 36: 1695-1702.
127. Rovira-Llopis S, Rocha M, Falcon R, et al. Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes? Antioxid Redox Signal 2013 Mar 25.
128. Hickey MJ, Sharkey KA, Sihota EG, et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 1997; 11: 955-964.
129. Hossain M, Qadri SM, Liu L. Inhibition of nitric oxide synthesis enhances leukocyte rolling and adhesion in human microvascula-ture. J Inflamm (Lond) 2012; 9: 28.
130. Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA. Reactive nitrogen and oxygen species attenuate interleukin-8-induced neutrophil chemotactic activity in vitro. J Biol Chem 2000; 275: 10826-10830.
131. Mach F, Sauty A, Iarossi AS, et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 1999; 104: 1041-1050.
132. Trifilieff A, Fujitani Y, Mentz F, Dugas B, Fuentes M, Bertrand C. Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol 2000; 165: 1526-1533.
133. Cherla RP, Ganu RK. Stromal cell-derived factor 1a-induced chemotaxis in T cells is mediated by itric oxide signaling pathways. J Immunol 2001; 166: 3067-3074.
134. Miller MW, Knaub LA, Olivera-Fragoso LF, et al. Nitric oxide regulates vascular adaptive mitochondrial dynamics. Am J Physiol Heart Circ Physiol 2013; 304(12): H1624-H1633.
135. Yang Z, Wang ZE, Doulias PT, et al. Lymphocyte development requires S-nitrosoglutathione reductase. J Immunol 2010; 185(11): 6664-6669.
136. Brüne B, von Knethen A, Sandau KB. Nitric oxide (NO): an effector of apoptosis. Cell Death Differ 1999; 6: 969-975.
137. Hammami I, Bertrand M, Chen J, Bronte V, De Crescenzo G, Joli-coeur M. Nitric oxide affects immune cells bioenergetics: long-term effects of nitric-oxide derivatives on leukaemic Jurkat cell metabolism. Immunobiology 2012; 217: 808-815.
138. Aiello S, Noris M, Piccinini G, et al. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens. J Immunol 2000; 164: 4649-4658.
139. Moulian N, Truffault F, Gaudry-Talarmain YM, Serraf A, Berrih-Aknin S. In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation. Blood 2001; 97: 3521-3530.
140. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
141. Kwak JY, Han MK, Choi KS, et al. Cytokines secreted by lym-phokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells. Cell Immunol 2000; 203: 84-94.
142. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H. The central role of CD4+ T cells in the antitumor immune response. J Exp Med 1998; 188: 2357-2368.
143. Xu W, Liu L, Smith GCM, Charles IG. Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumor agents. Nature Cell Biol 2000; 2: 339-345.
144. Kanasugi Y, Hamada N, Wada S, et al. Role of DNA-PKcs in the bystander effect after low- or high-LET irradiation. Int J Radiat Biol 2007; 83: 73-80.
145. Fernández V, Tapia G, Varela P, Cornejo P, Videla LA. Upregulation of liver inducible nitric oxide synthase following thyroid hormone preconditioning: suppression by N-acetylcysteine. Biol Res 2009; 42(4): 487-495.
146. Luckhart S, Vodovotz Y, Cui L, Rosenberg R. The mosquito Anopheles stephensi limits malaria parasite development with inducible nitric oxide synthesis. Proc Natl Acad Sci USA 1998; 95: 5700-5705.
147. Ribeiro JMC, Hazzard JMH, Nussenzweig RH, Champagne DE, Walker FA. Reversible binding of nitric oxide by a salivary heme protein from a bloodsucking insect. Science 1993; 260: 539-541.
148. Cuervo H, Pineda MA, Aoki MP, Gea S, Fresno M, Gironès N. Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages. J Infect Dis 2008; 197: 1772-1782.
149. Alam MS, Zaki MH, Sawa T, et al. Nitric oxide produced in Peyer's patches exhibits antiapoptotic activity contributing to an antimicrobial effect in murine salmonellosis. Microbiol Immunol 2008; 52(4): 197-208.
150. Balaña-Fouce R, Calvo-Álvarez E, Álvarez-Velilla R, Prada CF, Pérez-Pertejo Y, Reguera RM. Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis. Mol Biochem Parasitol 2012; 181: 85-93.
151. Hesse M, Cheever AW, Jankovic D, Wynn TA. NOS-2 mediates the protective anti-inflammatory and anti-fibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am J Pathol 2000; 157: 945-955.
152. van der Heyde HC, Gu Y, Zhang Q, Sun G, Grisham MB. Nitric oxide is neither necessary nor sufficient for resolution of Plasmodium chabaudi malaria in mice. J Immunol 2000; 165: 3317-3323.
153. Oztuzcu S, Igci YZ, Arslan A, et al. mRNA expressions of inducible nitric oxide synthase, endothelial nitric oxide synthase, and neuronal nitric oxide synthase genes in meningitis patients. Genet Test Mol Biomarkers 2011; 15: 147-152.
154. DeGroote MA, Fang FC. Antimicrobial properties of nitric oxide. In: Fang FC, Ed. Nitric oxide and infection. New York: Kluwer Academic/Plenum Publishers 1999; pp. 231-61.
155. Vazquez-Torres A, Jones-Carson J, Mastroeni P, Ischiropoulos H, Fang FC. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med 2000; 192: 227-236.
156. Bryk R, Griffin P, Nathan C. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 2000; 407: 211-215.
157. Piacenza L, Peluffo G, Radi R. L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: contribution of the nitric oxide and polyamine pathways. Proc Natl Acad Sci USA 2001; 98: 7301-7306.
158. Iniesta V, Gomez-Nieto LC, Corraliza I. The inhibition of arginase by Nn-hydroxy-L-arginine controls the growth of Leishmania inside macrophages. J Exp Med 2001; 193: 777-783.
159. Diefenbach A, Schindler H, Röllinghoff M, Yokoyama WM, Bogdan C. Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science 1999; 284(5416): 951-955.
160. Lee C, Miura K, Liu X, Zweier JL. Biphasic regulation of leukocyte superoxide generation by nitric oxide and peroxinitrite. J Biol Chem 2000; 275: 38965-38972.
161. Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S. Interferony eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 2000; 192: 117-122.
162. Saeftel M, Fleischer B, Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect Immun 2001; 69: 2252-2259.
163. Akaike T, Fujii S, Kato A, et al. Viral mutation accelerated by nitric oxide production during infection in vivo. FASEB J 2000; 14: 1147-1154.
164. Johansson CC, Mougiakakos D, Trocme E, et al. Expression and prognostic significance of iNOS in uveal melanoma. Int J Cancer 2010; 126: 2682-2689.
165. Weinberg, JB. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med 1998; 4, 557-591.
166. Adamson DC, Wildemann B, Sasaki M, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996; 274: 1917-1921.
167. Chiwakata CB, Hemmer CJ, Dietrich M. High levels of inducible nitric oxide synthase mRNA are associated with increased mono-cyte counts in blood and have a beneficial role in Plasmodium fal-ciparum malaria. Infect Immun 2000; 68, 394-399.
168. Maneerat Y, Viriyavejakul P, Punpoowong B, et al. Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria. Histopathology 2000; 37: 269-277.
169. Lee PC, Shears LL, Billiar TR. Role of inducible nitric oxide syn-thase in transplant atherosclerosis. Clin Exp Pharmacol Physiol 1999; 26: 1013-1015.
170. Vos IH, Joles JA, Schurink M, et al. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointersti-tial injury in renal allograft rejection. Eur J Pharmacol 2000; 391: 31-38.
171. Bobé P, Benihoud K, Grandjon D, Opolon P, Pritchard LL, Huchet R. Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction. Blood 1999; 94: 1028-1037.
172. Limbourg FP. A Quick Fix?: Short-term CXC-Chemokine receptor 4 inhibition redistributes proangiogenic bone marrow cells to ischemic myocardium in an endothelial nitric oxide synthase--dependent fashion. Circulation 2013; 127: 13-15.
173. McCartney-Francis NL, Song XY, Mizel DE, Wahl SM. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J Immunol 2001; 166: 2734-2740.
174. Shi FD, Flodström M, Kim SH, et al. Control of the autoimmune response by type 2 nitric oxide synthase. J Immunol 2001; 167: 3000-3006.
175. Cauwels A, Van Molle W, Janssen B, et al. Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase. Immunity 2000; 13: 223-231.
176. Ahmad R, Ahsan H. Role of peroxynitrite-modified biomolecules in the etiopathogenesis of systemic lupus erythematosus. Clin Exp Med 2012 Nov 23.
177. Vanasco V, Magnani ND, Cimolai MC, et al. Endotoxemia impairs heart mitochondrial function by decreasing electron transfer, ATP synthesis and ATP content without affecting membrane potential. J Bioenerg Biomembr 2012; 44(2): 243-252.